Gene: VPS8
Official Full Name: VPS8 subunit of CORVET complexprovided by HGNC
Gene Summary: Predicted to enable metal ion binding activity. Involved in endosomal vesicle fusion. Located in early endosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29393 | VPS8 Knockout cell line (HeLa) | Human | VPS8 | 1:3~1:6 | Negative | Online Inquiry |
KO29394 | VPS8 Knockout cell line (HCT 116) | Human | VPS8 | 1:2~1:4 | Negative | Online Inquiry |
KO29395 | VPS8 Knockout cell line (HEK293) | Human | VPS8 | 1:3~1:6 | Negative | Online Inquiry |
KO29396 | VPS8 Knockout cell line (A549) | Human | VPS8 | 1:3~1:4 | Negative | Online Inquiry |
VPS8 Gene Knockout Cell Lines are genetically engineered cell lines that have been specifically modified to lack the VPS8 gene, which encodes a protein involved in the endosomal trafficking system. By knocking out the VPS8 gene, these cell lines facilitate the study of intracellular transport dynamics and their implications in cellular processes such as autophagy, membrane recycling, and signaling mechanisms.
The primary function of VPS8 is its role in the assembly of the retromer complex, which is essential for retrograde transport of key proteins from endosomes back to the trans-Golgi network. By utilizing these knockout cell lines, researchers can examine the downstream effects of disrupted retromer function on various cellular pathways, offering insights into neurodegenerative diseases, certain cancers, and metabolic disorders where endosomal dysfunction is implicated.
Scientifically, the availability of VPS8 Gene Knockout Cell Lines is of paramount importance in both basic research and clinical settings. They provide a robust platform for investigating gene function, validating therapeutic targets, and understanding disease mechanisms that are central to numerous pathologies. In particular, they allow for high-throughput screening of potential drug candidates aimed at restoring normal endosomal trafficking.
One of the key advantages of our VPS8 Gene Knockout Cell Lines is their stringent genetic validation, ensuring that researchers are working with a reliable loss-of-function model. Additionally, these cell lines exhibit high uniformity, reducing variability in experimental outcomes compared to other knockout models. This specificity saves time and resources, allowing researchers to focus on more innovative aspects of their work.
In today's research landscape, understanding the complexity of cellular transport mechanisms has become increasingly vital, and our VPS8 Gene Knockout Cell Lines are designed to empower researchers with the tools they need to delve deeper into these processes. As a leader in biological products, our company is committed to providing high-quality, validated cell lines that meet rigorous scientific standards, enabling discoveries that push the boundaries of knowledge in cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.